255 related articles for article (PubMed ID: 11200867)
1. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects.
Don BR
Clin Nephrol; 2001 Jan; 55(1):45-52. PubMed ID: 11200867
[TBL] [Abstract][Full Text] [Related]
2. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
3. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
Yu KH; Luo SF; Tsai WP; Huang YY
Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
[TBL] [Abstract][Full Text] [Related]
4. Effect of cranberry juice consumption on urinary stone risk factors.
Gettman MT; Ogan K; Brinkley LJ; Adams-Huet B; Pak CY; Pearle MS
J Urol; 2005 Aug; 174(2):590-4; quiz 801. PubMed ID: 16006907
[TBL] [Abstract][Full Text] [Related]
5. AT1 blockers and uric acid metabolism: are there relevant differences?
Puig JG; Torres R; Ruilope LM
J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
[TBL] [Abstract][Full Text] [Related]
6. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
[TBL] [Abstract][Full Text] [Related]
7. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
8. Uricosuric therapy and urate solubility in blood and urine.
Gröbner W; Zöllner N
Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
[TBL] [Abstract][Full Text] [Related]
9. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders.
Puig JG; Torres RJ; de Miguel E; Sánchez A; Bailén R; Banegas JR
Metabolism; 2012 Apr; 61(4):512-8. PubMed ID: 22001332
[TBL] [Abstract][Full Text] [Related]
10. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
Henger A; Tutt P; Riesen WF; Hulter HN; Krapf R
J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465
[TBL] [Abstract][Full Text] [Related]
11. Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects.
Prasongwatana V; Woottisin S; Sriboonlue P; Kukongviriyapan V
J Ethnopharmacol; 2008 May; 117(3):491-5. PubMed ID: 18423919
[TBL] [Abstract][Full Text] [Related]
12. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
13. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
16. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation.
Siener R; Hesse A
Eur J Nutr; 2003 Dec; 42(6):332-7. PubMed ID: 14673606
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term beer ingestion on plasma concentrations and urinary excretion of purine bases.
Ka T; Moriwaki Y; Takahashi S; Yamamoto A; Tsutsumi Z; Inokuchi T; Yamamoto T
Horm Metab Res; 2005 Oct; 37(10):641-5. PubMed ID: 16278788
[TBL] [Abstract][Full Text] [Related]
19. [Correlative urinary excretion of sodium-uric acid in hyperuricemia (author's transl)].
Pérez Ortolá R; Picardo NG; Sánchez Palacios A
Med Clin (Barc); 1980 Feb; 74(3):95-7. PubMed ID: 7366280
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
Torres RJ; Prior C; Puig JG
Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
